Literature DB >> 1954923

Immunochemical techniques in biological monitoring.

M H Rosner1, J A Grassman, R A Haas.   

Abstract

Immunoassays are analytical methods that detect interactions between antibodies and antigens. Immunoassays were used originally to detect large biological molecules. The new generation of these antibody-based assays can detect small synthetic compounds. As a result, immunoassays are being developed specifically for biomarkers of exposure and effect to environmentally prevalent chemicals. Immunochemical detection of parent compounds in blood and tissues, metabolites in excreta, and adducts with DNA and protein have been successfully performed by several investigators. Although there is great potential for use of immunoassays in biological monitoring studies, the limitations of these analyses must be fully understood to prevent improper evaluation of the acquired data. This review will cover some of the background material necessary to understand how an antibody-based assay is developed. The differences between polyclonal and monoclonal antibody-based assays and the importance of antibody class, affinity, specificity, and cross-reactivity must be considered in both study design and data analysis.

Mesh:

Substances:

Year:  1991        PMID: 1954923      PMCID: PMC1567961          DOI: 10.1289/ehp.94-1567961

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  13 in total

1.  Determination of benzo[a]pyrene diol epoxide-DNA adducts in white blood cell DNA from coke-oven workers: the impact of smoking.

Authors:  F J van Schooten; F E van Leeuwen; M J Hillebrand; M E de Rijke; A A Hart; H G van Veen; S Oosterink; E Kriek
Journal:  J Natl Cancer Inst       Date:  1990-06-06       Impact factor: 13.506

Review 2.  Somatic generation of antibody diversity.

Authors:  S Tonegawa
Journal:  Nature       Date:  1983-04-14       Impact factor: 49.962

3.  The preparation of antigenic hapten-carrier conjugates: a survey.

Authors:  B F Erlanger
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

4.  Establishing clinical and immunologic criteria for diagnosis of occupational immunologic lung disease with phthalic anhydride and tetrachlorophthalic anhydride exposures as a model.

Authors:  L C Grammer; K E Harris; M J Chandler; D Flaherty; R Patterson
Journal:  J Occup Med       Date:  1987-10

5.  Anti-peptide antibodies detect oncogene-related proteins in urine.

Authors:  H L Niman; A M Thompson; A Yu; M Markman; J J Willems; K R Herwig; N A Habib; C B Wood; R A Houghten; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

6.  Detection of benzo[a]pyrene diol epoxide-DNA adducts in peripheral blood lymphocytes and antibodies to the adducts in serum from coke oven workers.

Authors:  C C Harris; K Vahakangas; M J Newman; G E Trivers; A Shamsuddin; N Sinopoli; D L Mann; W E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

7.  Detection of smoking-related covalent DNA adducts in human placenta.

Authors:  R B Everson; E Randerath; R M Santella; R C Cefalo; T A Avitts; K Randerath
Journal:  Science       Date:  1986-01-03       Impact factor: 47.728

8.  Serum screening for oncogene proteins in workers exposed to PCBs.

Authors:  P W Brandt-Rauf; H L Niman
Journal:  Br J Ind Med       Date:  1988-10

9.  Monitoring of individual human exposure to aflatoxins (AF) and N-nitrosamines (NNO) by immunoassays.

Authors:  C P Wild; D Umbenhauer; B Chapot; R Montesano
Journal:  J Cell Biochem       Date:  1986       Impact factor: 4.429

10.  Detection of benzo(a)pyrene:DNA adducts in human white blood cells.

Authors:  A K Shamsuddin; N T Sinopoli; K Hemminki; R R Boesch; C C Harris
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

View more
  1 in total

Review 1.  Immunological methods for nursing research: from cells to systems.

Authors:  Helena W Morrison; Charles A Downs
Journal:  Biol Res Nurs       Date:  2011-03-30       Impact factor: 2.522

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.